Process Analytical Technology (PAT) has dramatically expanded its capabilities over the last decade. Today鈥檚 PAT enables an in-depth understanding of process behaviour on both macroscopic and molecular levels, allowing users to accurately track the impact of process variables on system behaviour. Whether in a reactor, a continuous flow line, or a filter/dryer, kinetic mechanisms such as nucleation, growth, breakage, agglomeration, and 鈥渙iling out鈥� play a major role in downstream drug product manufacturing. Using next generation Blaze PAT, these mechanisms are understood in real-time such that they can be related to final crystal morphology, surface, size, and structure, which ultimately drive downstream processability.
In this talk, we will review the enabling improvements to the PAT landscape as they relate to drug substance and drug product manufacturing, and provide examples of how those improvements deepen process understanding, speed process development and in some cases enable new paths to process optimization.
In this talk, we will review the enabling improvements to the PAT landscape as they relate to drug substance and drug product manufacturing, and provide examples of how those improvements deepen process understanding, speed process development and in some cases enable new paths to process optimization.
